The table below shows PTC THERAPEUTICS, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$1.73B
$806.78M
$937.82M
$698.80M
$538.59M
$380.77M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$455.25M
$534.48M
$666.56M
$651.50M
$540.68M
$477.64M
SG&A
PTCT annual revenue (10-K history)
PTC THERAPEUTICS, INC. reported annual revenue of $1.73B for fiscal year 2025. That is up 114.5% from $806.78M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $82.70M (FY 2016) to $1.73B. Figures come from the company's audited annual reports as filed with the SEC.
